Risk Stratification of Periprocedural Myocardial Infarction after Percutaneous Coronary Intervention: Analysis Based on the SCAI Definition

被引:10
作者
Zhang, Dong
Li, Yiping
Yin, Dong
He, Yuan
Chen, Changzhe
Song, Chenxi
Yan, Ruohua
Zhu, Chen'gang
Xu, Bo
Dou, Kefei
机构
[1] Fuwai Hosp, Dept Cardiol, Cardiovasc Inst, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
[2] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
[3] Peking Union Med Coll, Beijing 100037, Peoples R China
关键词
percutaneous coronary intervention; periprocedural myocardial infarction; predictors; risk prediction; MORTALITY RISK; REVASCULARIZATION; ISOENZYME; FREQUENCY; IMPACT; DAMAGE; SCORE;
D O I
10.1002/ccd.26939
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To investigate the predictors of and generate a risk prediction method for periprocedural myocardial infarction (PMI) after percutaneous coronary intervention (PCI) using the new PMI definition proposed by the Society for Cardiovascular Angiography and Interventions (SCAI). Background: The SCAI-defined PMI was found to be associated with worse prognosis than the PMI diagnosed by other definitions. However, few large-sample studies have attempted to predict the risk of SCAI-defined PMI. Methods: A total of 3,371 patients (3,516 selective PCIs) were included in this single-center retrospective analysis. The diagnostic criteria for PMI were set according to the SCAI definition. All clinical characteristics, coronary angiography findings and PCI procedural factors were collected. Multivariate logistic regression analysis was performed to identify independent predictors of PMI. To evaluate the risk of PMI, a multivariable risk score (PMI score) was constructed with incremental weights attributed to each component variable according to their estimated coefficients. Results: PMI occurred in 108 (3.1%) of all patients. Age, multivessel treatment, at least one bifurcation treatment and total treated lesion length were independent predictors of SCAI-defined PMI. PMI scores ranged from 0 to 20. The C-statistic of PMI score was 0.71 (95% confidence interval: 0.66-0.76). PMI rates increased significantly from 1.96% in the non-high-risk group (PMI score < 10) to 6.26% in the high-risk group (PMI score >= 10) ( P < 0.001). Conclusions: Age, multivessel treatment, at least one bifurcation treatment, and total treated lesion length are predictive of PMI. The PMI score could help identify patients at high risk of PMI after PCI. (C) 2017 Wiley Periodicals, Inc.
引用
收藏
页码:534 / 540
页数:7
相关论文
共 26 条
[1]   Minor myocardial damage and prognosis - Are spontaneous and percutaneous coronary intervention-related events different? [J].
Akkerhuis, KM ;
Alexander, JH ;
Tardiff, BE ;
Boersma, E ;
Harrington, RA ;
Lincoff, AM ;
Simoons, ML .
CIRCULATION, 2002, 105 (05) :554-556
[2]  
[Anonymous], 2007, J AM COLL CARDIOL, DOI [DOI 10.1016/J.JACC.2007.09.011, DOI 10.1016/j.jacc.2007.09.011]
[3]   Use and misuse of the receiver operating characteristic curve in risk prediction [J].
Cook, Nancy R. .
CIRCULATION, 2007, 115 (07) :928-935
[4]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[5]   Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial [J].
Di Sciascio, Germano ;
Patti, Giuseppe ;
Pasceri, Vincenzo ;
Gaspardone, Achille ;
Colonna, Giuseppe ;
Montinaro, Antonio .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (06) :558-565
[6]   Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation A substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial [J].
Farooq, Vasim ;
Serruys, Patrick W. ;
Vranckx, Pascal ;
Bourantas, Christos V. ;
Girasis, Chrysafios ;
Holmes, David R. ;
Kappetein, Arie Pieter ;
Mack, Michael ;
Feldman, Ted ;
Morice, Marie Claude ;
Colombo, Antonio ;
Morel, Marie-angele ;
de Vries, Ton ;
Dawkins, Keith D. ;
Mohr, Friedrich W. ;
James, Stefan ;
Stahle, Elisabeth .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (06) :5287-5292
[7]   Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction [J].
Herrmann, J ;
Lerman, A ;
Baumgart, D ;
Volbracht, L ;
Schulz, R ;
von Birgelen, C ;
Haude, M ;
Heusch, G ;
Erbel, R .
CIRCULATION, 2002, 106 (17) :2180-2183
[8]  
Hosmer DW, 1997, STAT MED, V16, P965
[9]   Varying Definitions for Periprocedural Myocardial Infarction Alter Event Rates and Prognostic Implications [J].
Idris, Hanan ;
Lo, Sidney ;
Shugman, Ibrahim M. ;
Saad, Yousef ;
Hopkins, Andrew P. ;
Mussap, Christian ;
Leung, Dominic ;
Thomas, Liza ;
Juergens, Craig P. ;
French, John K. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (06)
[10]   Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention [J].
Ioannidis, JPA ;
Karvouni, E ;
Katritsis, DG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (08) :1406-1411